독성학 약물 스크리닝 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 시험 유형별, 제품별, 용도별, 지역별, 경쟁별 세분화(2020-2030년)
Toxicology Drug Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Testing Type, By Product, By Application, By Region, By Competition, 2020-2030F
상품코드:1886361
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 독성학 약물 스크리닝 시장은 2024년 121억 6,000만 달러에서 2030년까지 198억 4,000만 달러로, CAGR 8.50%로 확대할 전망입니다. 독성학 약물 스크리닝은 신약 개발 및 개발 초기 단계에서 신약 화합물이 생물학적 시스템에 미치는 잠재적 부작용을 체계적으로 평가하는 과정을 말합니다. 본 시장의 확대는 기본적으로 임상시험을 진행하기 전에 엄격한 안전성 평가가 필요한 세계 의약품의 연구개발비 증가에 의해 촉진되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
121억 6,000만 달러
시장 규모 : 2030년
198억 4,000만 달러
CAGR : 2025-2030년
8.50%
가장 빠르게 성장하는 부문
인실리코
최대 시장
북미
주요 시장 성장 촉진요인
세계 약물 독성 스크리닝 시장의 확대는 제약 분야의 R&D 투자 증가에 의해 크게 영향을 받고 있습니다. 제약회사들이 신약 후보물질의 발견과 개발에 많은 자본을 투자함에 따라 종합적이고 초기 단계의 독성 평가에 대한 필요성이 점점 더 커지고 있습니다.
주요 시장 과제
세계 독성학 약물 스크리닝 시장에 영향을 미치는 주요 과제는 *in vivo*(생체 내) 인체 독성을 정확하게 예측하는 *in vitro*(시험관 내) 모델 개발 및 검증에 따른 상당한 복잡성과 고유한 비용입니다. 이는 첨단 스크리닝 기술의 보급에 큰 장벽을 만들어 시장 확대를 직접적으로 방해하고 있습니다.
주요 시장 동향
세계 독성학 약물 스크리닝 시장은 장기 칩 및 3D 세포배양 기술과 같은 복잡한 in vitro 모델의 발전에 의해 크게 형성되고 있습니다. 이러한 모델은 기존 2D 세포배양에 비해 생리적 연관성이 향상되어 인간의 생물학 및 약물 반응을 보다 정확하게 재현합니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 독성학 약물 스크리닝 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
시험 방법별(In Vitro, In Vivo, In Silico)
제품별(기기, 시약·소모품, 동물 모델, 소프트웨어, 기타 제품)
용도별(면역독성, 전신 독성, 발생·생식 독성(DART), 내분비 교란, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 독성학 약물 스크리닝 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 독성학 약물 스크리닝 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 독성학 약물 스크리닝 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 독성학 약물 스크리닝 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 독성학 약물 스크리닝 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 독성학 약물 스크리닝 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Merck KGaA
Charles River Laboratories International, Inc.
Enzo Life Sciences Inc.
Eurofins Scientific SE
Danaher Corporation
Laboratory Corporation of America Holdings
Promega Corporation
The Jackson Laboratory
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Toxicology Drug Screening Market will grow from USD 12.16 Billion in 2024 to USD 19.84 Billion by 2030 at a 8.50% CAGR. Toxicology drug screening involves the systematic evaluation of potential adverse effects of novel pharmaceutical compounds on biological systems during the initial stages of drug discovery and development. This market's expansion is fundamentally propelled by escalating global pharmaceutical research and development expenditures, which necessitate rigorous safety assessments before advancing to clinical trials.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 12.16 Billion
Market Size 2030
USD 19.84 Billion
CAGR 2025-2030
8.50%
Fastest Growing Segment
In Silico
Largest Market
North America
Key Market Drivers
The expansion of the global toxicology drug screening market is significantly influenced by increasing pharmaceutical research and development investments. As pharmaceutical companies commit substantial capital to the discovery and development of novel drug candidates, the imperative for comprehensive and early-stage toxicity assessment grows. This commitment is exemplified by major industry players.
Key Market Challenges
A key challenging factor impacting the global toxicology drug screening market is the considerable complexity and inherent costs associated with developing and validating *in vitro* models that accurately forecast *in vivo* human toxicity. This directly hampers market expansion by creating significant barriers to the widespread adoption of advanced screening technologies. Pharmaceutical companies face substantial financial outlays in both the initial development and the subsequent rigorous validation required to ensure these *in vitro* models reliably predict human physiological responses.
Key Market Trends
The global toxicology drug screening market is significantly shaped by advancements in complex in vitro models, such as organ-on-a-chip and 3D cell culture technologies. These models offer enhanced physiological relevance compared to traditional 2D cell cultures, providing a more accurate representation of human biology and drug responses. Their adoption helps to reduce reliance on animal testing and can improve the predictive accuracy of preclinical toxicity assessments.
Key Market Players
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Merck KGaA
Charles River Laboratories International, Inc.
Enzo Life Sciences Inc.
Eurofins Scientific SE
Danaher Corporation
Laboratory Corporation of America Holdings
Promega Corporation
The Jackson Laboratory
Report Scope:
In this report, the Global Toxicology Drug Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Toxicology Drug Screening Market, By Testing Type:
In Vitro
In Vivo
In Silico
Toxicology Drug Screening Market, By Product:
Instruments
Reagents and Consumables
Animal Models
Software
Other Products
Toxicology Drug Screening Market, By Application:
Immunotoxicity
Systemic toxicity
Developmental and Reproductive Toxicity (DART)
Endocrine Disruption
Other
Toxicology Drug Screening Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Toxicology Drug Screening Market.
Available Customizations:
Global Toxicology Drug Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Toxicology Drug Screening Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Testing Type (In Vitro, In Vivo, In Silico)
5.2.2. By Product (Instruments, Reagents and Consumables, Animal Models, Software, Other Products)
5.2.3. By Application (Immunotoxicity, Systemic toxicity, Developmental and Reproductive Toxicity (DART), Endocrine Disruption, Other)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Toxicology Drug Screening Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Testing Type
6.2.2. By Product
6.2.3. By Application
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Toxicology Drug Screening Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Testing Type
6.3.1.2.2. By Product
6.3.1.2.3. By Application
6.3.2. Canada Toxicology Drug Screening Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Testing Type
6.3.2.2.2. By Product
6.3.2.2.3. By Application
6.3.3. Mexico Toxicology Drug Screening Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Testing Type
6.3.3.2.2. By Product
6.3.3.2.3. By Application
7. Europe Toxicology Drug Screening Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Testing Type
7.2.2. By Product
7.2.3. By Application
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Toxicology Drug Screening Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Testing Type
7.3.1.2.2. By Product
7.3.1.2.3. By Application
7.3.2. France Toxicology Drug Screening Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Testing Type
7.3.2.2.2. By Product
7.3.2.2.3. By Application
7.3.3. United Kingdom Toxicology Drug Screening Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Testing Type
7.3.3.2.2. By Product
7.3.3.2.3. By Application
7.3.4. Italy Toxicology Drug Screening Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Testing Type
7.3.4.2.2. By Product
7.3.4.2.3. By Application
7.3.5. Spain Toxicology Drug Screening Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Testing Type
7.3.5.2.2. By Product
7.3.5.2.3. By Application
8. Asia Pacific Toxicology Drug Screening Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Testing Type
8.2.2. By Product
8.2.3. By Application
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Toxicology Drug Screening Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Testing Type
8.3.1.2.2. By Product
8.3.1.2.3. By Application
8.3.2. India Toxicology Drug Screening Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Testing Type
8.3.2.2.2. By Product
8.3.2.2.3. By Application
8.3.3. Japan Toxicology Drug Screening Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Testing Type
8.3.3.2.2. By Product
8.3.3.2.3. By Application
8.3.4. South Korea Toxicology Drug Screening Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Testing Type
8.3.4.2.2. By Product
8.3.4.2.3. By Application
8.3.5. Australia Toxicology Drug Screening Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Testing Type
8.3.5.2.2. By Product
8.3.5.2.3. By Application
9. Middle East & Africa Toxicology Drug Screening Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Testing Type
9.2.2. By Product
9.2.3. By Application
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Toxicology Drug Screening Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Testing Type
9.3.1.2.2. By Product
9.3.1.2.3. By Application
9.3.2. UAE Toxicology Drug Screening Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Testing Type
9.3.2.2.2. By Product
9.3.2.2.3. By Application
9.3.3. South Africa Toxicology Drug Screening Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Testing Type
9.3.3.2.2. By Product
9.3.3.2.3. By Application
10. South America Toxicology Drug Screening Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Testing Type
10.2.2. By Product
10.2.3. By Application
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Toxicology Drug Screening Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Testing Type
10.3.1.2.2. By Product
10.3.1.2.3. By Application
10.3.2. Colombia Toxicology Drug Screening Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Testing Type
10.3.2.2.2. By Product
10.3.2.2.3. By Application
10.3.3. Argentina Toxicology Drug Screening Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Testing Type
10.3.3.2.2. By Product
10.3.3.2.3. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Toxicology Drug Screening Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Bio-Rad Laboratories, Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Agilent Technologies, Inc.
15.3. Merck KGaA
15.4. Charles River Laboratories International, Inc.
